Brief: Mauna Kea Updates On Cellvizio In Detection Of Esophageal Dysplasia And Cancer
July 6 (Reuters) - Mauna Kea Technologies SAS MKEA.PA :
* PUBLICATION OF METAANALYSIS DEMONSTRATING SIGNIFICANT ROLE
OF
CELLVIZIO IN DETECTION OF ESOPHAGEAL DYSPLASIA AND CANCER
* RESULTS DEMONSTRATE SIGNIFICANT INCREASE IN DETECTION RATE
OF
NEOPLASIA WHEN CELLVIZIO IS USED AS ADJUNCT TO STANDARD
DIAGNOSTIC METHOD, HIGHLIGHTING KEY ROLE OF ADVANCED IMAGING IN
FIGHT AGAINST DEVELOPMENT RAPID ESOPHAGEAL CANCER
Further company coverage: MKEA.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Mauna Kea Technologies SA
See all newsBrief: Mauna Kea Technologies Confirms Trajectory Toward Profitability By Year-End 2027
Brief: Mauna Kea Technologies Announces Results Of Its Combined General Meeting
French and Benelux stocks-Factors to watch 21 Nov
Brief: Mauna Kea Technologies Receives NMPA Regulatory Approval In China For Its Next-Generation Cellvizio Platform
Europe Research Roundup: Craneware, Croda, Genus